Alcon Urges Dismissal Of Drug Bottle Size Class Action

Law360, New York (May 7, 2013, 3:39 PM EDT) -- Alcon Laboratories Inc. on Monday asked an Illinois federal judge to dismiss a putative class action accusing it of forcing consumers to buy bottles containing more prescription medicine than needed for effective treatment, arguing the plaintiff has no legitimate claim under state law for the federally regulated drugs.

According to the eye treatment specialist, plaintiff Carmen Fields' claim that Alcon only sells anti-inflammatory Nevanac or antibacterials Moxeza and Vigamox in containers with substantially more of the drugs than the typical patient ever uses, unfairly requiring consumers...
To view the full article, register now.